Artículos del autor

Dr. Andrés Rodríguez

Member of the Editorial Board of solaci.org
Structural heart disease

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry,...
Dr. Andrés Rodríguez -
Structural Heart Disease

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical...
Dr. Andrés Rodríguez -
Antiplatelet

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026,...
Dr. Andrés Rodríguez -
Acute coronary syndromes

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini...
Dr. Andrés Rodríguez -
Antiplatelet

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients...
Dr. Andrés Rodríguez -
Left Atrial Apendix Closure

Left Atrial Appendage Closure: Implantation Depth Could Determine Thrombosis Risk

Left atrial appendage closure (LAAC) has undergone significant advances over the past two decades. This progress has...
Dr. Andrés Rodríguez -
Chronic Coronary Syndromes

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in...
Dr. Andrés Rodríguez -
Acute coronary syndromes

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents...
Dr. Andrés Rodríguez -